InvestorsHub Logo
Followers 78
Posts 11422
Boards Moderated 0
Alias Born 04/03/2014

Re: None

Monday, 07/30/2018 8:49:33 PM

Monday, July 30, 2018 8:49:33 PM

Post# of 3881
Heard the conf call - key points

1. All were treating as a successful trial

2. The Q&A session was good but no one asked much about the 52 week results

3. One answer was - the main trial was 26 weeks and the 52 week was an extension. The trial was not powered for 52 week results. They were happy about 16 and 26 weeks results

4. All data is not available - when they get it they will meet with FDA - in Q4-2018 and decide about the final P3 trial design

Not sure what to make out of the results - market clearly did not like it

http://ir.redhillbio.com/static-files/35b7a3f0-37d1-47bf-8a7d-7f8dce159732
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RDHL News